In a significant stride towards self-reliance, Naprod Life Science is at the forefront of India's burgeoning pharmaceutical sector, particularly in the production of high-quality cancer medicines. Operating in over 40 regulated markets worldwide, the company exemplifies India's capability to meet global demand with innovative and affordable healthcare solutions. Mohan Jain, Director of Naprod Life Science in an exclusive interview with Shardul Nautiyal discusses Naprod's competitive edge, the importance of an integrated supply chain, and future plans to expand their footprint in regulated markets while navigating the challenges of the global pharmaceutical landscape.
Naprod Life Science leads India's self-reliant surge in global cancer drug market
July 27, 2025
Disclaimer: The information presented in this article is for informational and educational purposes only. While every effort has been made to ensure data accuracy and reliability, readers are advised to independently verify all figures, regulations, and market insights before making any business or investment decisions.
Category: Pharma Interviews
